Compliance » DOJ Going After Interlocking Directorates

DOJ Going After Interlocking Directorates

Symbolic illustration. Small silhouette figure holding a huge magnifying glass against an oversized page of text.

The Antitrust Division of the DOJ’s push to rigorously scrutinize interlocking directorates has forced some recent changes on corporate boards. It recently announced that five directors had resigned from four boards, and one company declined to exercise board appointment rights. The actions affected companies from the software, transportation, and insurance sectors. The board appointment rights of private equity firms, which allowed for different representatives on competing firms’ boards, were the issue at three of the interlocks. A fourth involved competing IT companies sharing a common director. The chair of the Senate Judiciary Committee recently called on the Federal Trade Commission to examine interlocking directorates in the pharmaceutical industry. The enforcement has yet to involve consent agreements or civil penalties, meaning the actions are not precedential. The DOJ has mostly relied on SEC filings to identify competing corporations.

Get our free daily newsletter

Subscribe for the latest news and business legal developments.

Read this next

Legal Ops Need to Assess Their Information Governance Programs

The AI Executive Order’s Impact on the Healthcare Industry

President Biden’s Executive Order on the Safe, Secure, and Trustworthy Development and […]

14 Proven Tactics to Elevate Your Law Firm's Webinars and Drive Results

Cybersecurity Agency Warns About Hacking Collective

The Cybersecurity and Infrastructure Security Agency and the FBI have issued a […]

Understanding Quantum Security Essential In Mitigating Risk Of Newest Cyber Threat

Data Privacy and Reputation Concerns About Adopting AI

Reputational damage was the greatest source of concern about AI, followed by […]

Scroll to Top